| Joseph Reinoso, | |
|
141 Keddie St, Fallon, NV 89406-2820 | |
| (775) 423-7141 | |
| Not Available |
| Full Name | Joseph Reinoso |
|---|---|
| Gender | Male |
| Speciality | Counselor - Mental Health |
| Location | 141 Keddie St, Fallon, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942966684 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Secondary |
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Reinoso, 141 Keddie St, Fallon, NV 89406-2820 Ph: () - | Joseph Reinoso, 141 Keddie St, Fallon, NV 89406-2820 Ph: (775) 423-7141 |
News Archive
WHILE cancer statistics for the last 10 years make encouraging reading, more needs to be done globally to fight the killer disease.
On Capitol Hill today, colorectal cancer experts and advocates will gather to promote the establishment of a national colorectal cancer screening program in an effort to save lives.
A new study examining the risk of fasting during Ramadan for people with type 1 diabetes compared blood glucose control and the rates of hypoglycemia and hyperglycemia between users of insulin pump therapy versus multiple daily insulin injections.
Neos Therapeutics, Inc. ("Neos" or "the Company"), a highly differentiated oral drug delivery company with an exciting portfolio of proprietary technologies and a late-stage pipeline of innovative controlled release (CR) products for ADHD, announced today that it has completed an oversubscribed round of private financing, raising a total of $15.5 million.
› Verified 1 days ago